Carolyn Bramante

Study from Former KL2 Scholar Shows Metformin Lowers the Risk of Getting Long COVID

In a new study published in The Lancet Infectious Diseases, a team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID. Former KL2 scholar Carolyn Bramante, MD, is the principal investigator.

Other News

A mural on the outside of the Community-University Health Care Center
The U of M’s Community-University Health Care Center is a beacon of health and wellness in the Twin Cities.
UMN students walking on campus in the wintertime
Take a moment to celebrate the extraordinary accomplishments of our health sciences community.
People walking on treadmills
As we age, maintaining bone health becomes even more important.